Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(208 products)
- Annexin A(11 products)
- Aromatase(20 products)
- Estrogen/progestogen Receptor(48 products)
- GPR(1 products)
- Glucocorticoid Receptor(153 products)
- LHRH(1 products)
- Opioid Receptor(297 products)
- Prostaglandin Receptor(119 products)
- RAAS(86 products)
- Reductase(52 products)
- Somatostatin(46 products)
- Thyroid hormone receptor(THR)(26 products)
- Vasopressin Receptor(44 products)
Show 6 more subcategories
Found 3180 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ro 64-6198
CAS:<p>Ro 64-6198: Nonpeptide, selective NOP agonist, high brain uptake, EC50=25.6 nM, 100x NOP>opioid affinity.</p>Formula:C26H31N3OPurity:98%Color and Shape:SolidMolecular weight:401.54CP-472555
CAS:<p>CP-472555 is a selective nonsteroidal glucocorticoid receptor antagonist with anti-GR and anti-obesity activity in animal models.</p>Formula:C31H32N2O2Color and Shape:SolidMolecular weight:464.604A7C-301
<p>4A7C-301, a Nurr1 agonist, exhibits potent neuroprotective effects in vitro and markedly mitigates neuropathological abnormalities while enhancing motor and</p>Color and Shape:Odour SolidRLA-4842
<p>RLA-4842: iron-based anti-androgen; inhibits mCRPC cell proliferation.</p>Formula:C42H46F3N5O8SColor and Shape:SolidMolecular weight:837.9ARCC-4
CAS:<p>ARCC-4: A VHL-recruiting, low-nanomolar (DC50=5nM) AR degrader; outshines enzalutamide; degrades AR mutants resistant to therapy.</p>Formula:C53H56F3N7O7S2Purity:98%Color and Shape:SolidMolecular weight:1024.18ST-CY14
<p>ST-CY14 is an inhibitor of the Nur77-PPARγ interaction with an EC50 of 3.15 μM. It binds to Nur77 (Kd=32 nM) to prevent its ubiquitination and degradation by PPARγ, reducing fatty acid uptake and mitochondrial respiration, and inhibiting the transcription of CD36 and FABP4. ST-CY14 suppresses proliferation and migration of MCF7 and MDA-MB-231 cancer cells and impedes tumor growth and bone metastasis in mouse models.</p>Formula:C139H237N57O31S2Color and Shape:SolidMolecular weight:3266.86L 363564
CAS:<p>L 363564 is a kidney renin inhibitor.</p>Formula:C54H76N12O10Color and Shape:SolidMolecular weight:1053.276Estrogen receptor modulator 13
<p>Estrogen receptor modulator13 (Compound 5D) is an estrogen receptor antagonist with significant cytotoxic effects on MCF7 cells, exhibiting an IC50 value of 8.50 μM. Estrogen receptor modulator13 holds potential for breast cancer research.</p>Formula:C25H19ClN2O2SColor and Shape:SolidMolecular weight:446.08558ARD-69
<p>ARD-69, a potent PROTAC, degrades AR in prostate cancer, with low DC50 values in AR+ cell lines, and suppresses AR gene expression.</p>Formula:C62H74ClFN8O7SColor and Shape:SolidMolecular weight:1129.83BI 653048 phosphate
CAS:<p>BI 653048 phosphate is a selective and orally active agonist of nonsteroidal glucocorticoid (GC)(IC50 : 55 nM).</p>Formula:C23H28F4N3O8PSPurity:98%Color and Shape:SolidMolecular weight:613.52Enclomiphene-d4
<p>Enclomiphene-d4 is the deuterium-labeled analog of Enclomiphene. Enclomiphene functions as a potent and orally active estrogen receptor antagonist, exhibiting antiestrogenic properties.</p>Color and Shape:Odour SolidHINT1-IN-1
<p>HINT1-IN-1 (compound 8) is an inhibitor of histidine triad nucleotide-binding protein 1 (HINT1) with a Ki of 1.14 μM. It influences the cross-regulation between μ-opioid receptors (MOR) and NMDA receptors (NMDAR).</p>Formula:C23H24N8O5Color and Shape:SolidMolecular weight:492.49PROTAC AR-V7 degrader-1
CAS:<p>Potent, oral AR-V7 degrader (Compound 6); DC50: 0.32µM; targets AR-DBD via VHL E3; EC50: 0.88µM in 22Rv1 cells.</p>Formula:C41H52N6O6S2Color and Shape:SolidMolecular weight:789.02Olmesartan medoxomil impurity C
CAS:<p>Impurity C of Olmesartan medoxomil is a selective AT1 inhibitor with an IC50 of 66.2 μM.</p>Formula:C29H28N6O5Color and Shape:SolidMolecular weight:540.57Azilsartan Medoxomil Potassium
CAS:<p>Azilsartan Medoxomil Potassium (TAK-491 Potassium) is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension.</p>Formula:C30H23N4O8·KPurity:98.72%Color and Shape:SolidMolecular weight:606.62Parathyroid hormone (1-34) (rat)
CAS:<p>Parathyroid hormone (PTH) receptor agonist. Increases serum PTH levels and bone mass in rats.</p>Formula:C180H291N55O48S2Purity:98%Color and Shape:SolidMolecular weight:4057.74D3R/MOR antagonist 2
<p>Compound 121, a D3R/MOR antagonist with K i values of 361 nM and 85.2 nM for D3R and MOR respectively, has the potential for analgesic effects through MOR</p>Formula:C25H31ClN2OPurity:98%Color and Shape:SolidMolecular weight:410.98Hydrocortisone sodium succinate
CAS:<p>Hydrocortisone sodium succinate is a glucocorticoid which is used to alleviate allergic reactions, particularly those of the skin and gums.</p>Formula:C25H34NaO8Color and Shape:SolidMolecular weight:485.529PROTAC AR Degrader-4 TFA
<p>PROTAC AR Degrader-4: IAP ligand, linker, AR binder; it's a SNIPER that degrades AR non-genetically.</p>Formula:C45H68F3N3O11Color and Shape:SolidMolecular weight:884.03Biphalin TFA
CAS:<p>Biphalin TFA is an opioid peptide analog that penetrates the blood-brain barrier (BBB) and encompasses two active enkephalin pharmacophores.</p>Formula:C46H56N10O10·xC2HF3O2Purity:98%Color and Shape:SolidMolecular weight:909.00 (free base)
